FERRETTI (09638) continues to advance the reorganization of technical and operational functions to accelerate innovation and industrial excellence.
FERRETTI (09638) announced that the group continues to advance its organizational transformation, carrying out a major reorganization of its technical and operational functions, aimed at substantially strengthening the group's technical capabilities, accelerating product development and innovation, and further enhancing manufacturing excellence and product quality.
FERRETTI (09638) announces that the Group continues to advance its organizational transformation, carrying out a major reorganization of its technical and operational functions, aimed at substantially strengthening the Group's technical capabilities, accelerating product development and innovation, and further enhancing manufacturing excellence and product quality.
The Company's Chief Technical and Operating Officer, Mr. Matteo Cecada, will leave the Group. His last working day with the Company will be December 1, 2026.
To this end, the Group has decided to establish three independent areas, each reporting directly to Chief Executive Officer Mr. Stassi Anastassov: 1. Mr. Marco Ricci Chief Manufacturing Officer, responsible for production operations, shipyards, industrial efficiency, infrastructure and procurement; 2. Mr. Danilo Giunchi Chief R&D Officer, responsible for engineering, product development, research and proprietary technology; 3. Mr. Massimiliano Amato Chief Customer and Improvement Officer, responsible for product quality, testing, delivery quality and continuous improvement, with a strong focus on shipowner satisfaction.
Related Articles

US Stock Market Move | Crypto-related stocks broadly rise; Hut 8 (HUT.US) gains over 14%.

US Stock Market Move | Q3 innovative drug revenue up 33% year-over-year; Teva Pharmaceutical Industries Limited Sponsored ADR (TEVA.US) rises over 4%.

Suzhou Dongshan Precision Manufacturing (02384)'s controlling shareholder proposes a total shareholder return of no less than RMB1 billion for 2026.
US Stock Market Move | Crypto-related stocks broadly rise; Hut 8 (HUT.US) gains over 14%.

US Stock Market Move | Q3 innovative drug revenue up 33% year-over-year; Teva Pharmaceutical Industries Limited Sponsored ADR (TEVA.US) rises over 4%.

Suzhou Dongshan Precision Manufacturing (02384)'s controlling shareholder proposes a total shareholder return of no less than RMB1 billion for 2026.






